Article(id=1330184372222799926, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.06.018, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1663603200000, receivedDateStr=2022-09-20, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070267968, onlineDateStr=2026-11-19, pubDate=1686326400000, pubDateStr=2023-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070267968, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070267968, creator=13701087609, updateTime=1795070267968, updator=13701087609, issue=Issue{id=1330184264366272602, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='6', pageStart='813', pageEnd='981', issueExtLink='null', onlineDate='null', pubDate='1686326400000', pubDateStr='2023-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070242253, creator='13701087609', updateTime=1795080494688, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227266719691144, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227266719691145, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=957, endPage=964, ext={EN=ArticleExt(id=1330184372415737911, articleId=1330184372222799926, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Status and Analysis of Domestic and Foreign Laws and Regulations on Accelerated CMC Development and Registration of Innovative Therapeutic Biological Products, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Xianglin LYU
1, Yaying WANG
2, Xiaohua ZHANG
2, Ming CHEN
2, Linqi ZHANG
1, authorsList=Xianglin LYU, Yaying WANG, Xiaohua ZHANG, Ming CHEN, Linqi ZHANG, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330184373393010745, articleId=1330184372222799926, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=加速创新型治疗用生物制品CMC开发与注册的国内外法规现状与分析, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=
我国正式加入人用药品技术要求国际协调理事会(ICH),药品审评审批制度改革以及新法规指导原则的实施,为鼓励创新药在全球的同步开发和上市创造了良好的环境。近年来,为支持有迫切临床需求的创新药尽快上市,国内外药品监管机构陆续出台了多种加速途径。化学、制造和控制(CMC)与临床研究的同步开发直接关系到临床研究样品和上市产品的供应,创新药整体开发进程的加速给常规的CMC开发速度带来新的挑战。该文通过对目前国内外相关法规和文献的梳理和分析,探讨了如何基于风险-获益平衡的思想科学监管,通过新技术、生产和控制策略的引入加速CMC开发,以支持创新药更快进入临床研究以及更快上市惠及患者。
, authors=吕香霖
1, 王雅英
2, 张小华
2, 陈明
2, 张林琦
1, authorsList=吕香霖, 王雅英, 张小华, 陈明, 张林琦, authorCompany=null, correspAuthors=null, authorNote=
, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=9w/rVGZH8tn+xiOq1gYjSg==, magXml=F6KZO4owRS4xRU7QsjLFJw==, pdfUrl=null, pdf=fDQ28nYMsfOsKxE28U3xrw==, pdfFileSize=1526744, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=weS7IY8ekcCUXA7j//zENg==, mapNumber=null, fund=null)}, authors=[Author(id=1330184374609358913, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xianglinlv@aliyun.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184374701633603, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184374609358913, language=EN, stringName=Xianglin LYU, firstName=Xianglin, middleName=null, lastName=LYU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.School of Medicine, Tsinghua University, Beijing 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184374798102596, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184374609358913, language=CN, stringName=吕香霖, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.清华医学院,北京 100084, bio={"content":"
吕香霖(1989—),女,博士,从事药品监管科学的研究。E-mail:xianglinlv@aliyun.com
"}, bioImg=null, bioContent=
吕香霖(1989—),女,博士,从事药品监管科学的研究。E-mail:xianglinlv@aliyun.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184374454169658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, xref=1., ext=[AuthorCompanyExt(id=1330184374462558267, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374454169658, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Medicine, Tsinghua University, Beijing 100084), AuthorCompanyExt(id=1330184374470946876, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374454169658, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.清华医学院,北京 100084)])]), Author(id=1330184374869405767, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184374944903241, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184374869405767, language=EN, stringName=Yaying WANG, firstName=Yaying, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.GlaxoSmithKline Company, Beijing 100025, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184375003623498, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184374869405767, language=CN, stringName=王雅英, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.葛兰素史克公司,北京 100025, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184374533861437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, xref=2., ext=[AuthorCompanyExt(id=1330184374542250046, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374533861437, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.GlaxoSmithKline Company, Beijing 100025), AuthorCompanyExt(id=1330184374550638655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374533861437, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.葛兰素史克公司,北京 100025)])]), Author(id=1330184375074926668, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184375154618446, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184375074926668, language=EN, stringName=Xiaohua ZHANG, firstName=Xiaohua, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.GlaxoSmithKline Company, Beijing 100025, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184375217533007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184375074926668, language=CN, stringName=张小华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.葛兰素史克公司,北京 100025, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184374533861437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, xref=2., ext=[AuthorCompanyExt(id=1330184374542250046, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374533861437, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.GlaxoSmithKline Company, Beijing 100025), AuthorCompanyExt(id=1330184374550638655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374533861437, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.葛兰素史克公司,北京 100025)])]), Author(id=1330184375293030481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184375385305171, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184375293030481, language=EN, stringName=Ming CHEN, firstName=Ming, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.GlaxoSmithKline Company, Beijing 100025, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184375464996948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184375293030481, language=CN, stringName=陈明, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.葛兰素史克公司,北京 100025, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184374533861437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, xref=2., ext=[AuthorCompanyExt(id=1330184374542250046, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374533861437, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.GlaxoSmithKline Company, Beijing 100025), AuthorCompanyExt(id=1330184374550638655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374533861437, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.葛兰素史克公司,北京 100025)])]), Author(id=1330184375536300118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184375603408984, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184375536300118, language=EN, stringName=Linqi ZHANG, firstName=Linqi, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.School of Medicine, Tsinghua University, Beijing 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184375674712153, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, authorId=1330184375536300118, language=CN, stringName=张林琦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.清华医学院,北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184374454169658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, xref=1., ext=[AuthorCompanyExt(id=1330184374462558267, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374454169658, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Medicine, Tsinghua University, Beijing 100084), AuthorCompanyExt(id=1330184374470946876, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374454169658, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.清华医学院,北京 100084)])])], keywords=[Keyword(id=1330184375766986842, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, language=CN, orderNo=1, keyword=CMC), Keyword(id=1330184375846678620, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, language=CN, orderNo=2, keyword=创新型治疗用生物制品), Keyword(id=1330184375917981789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, language=CN, orderNo=3, keyword=药品加快上市程序)], refs=[Reference(id=1330184376014450782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=STEWART D J, STEWART A A, WHEATLEY‐PRICE P,
et al. The importance of greater speed in drug development for advanced malignancies [J].
Cancer Med, 2018,
7(5):1824-1836., articleTitle=null, refAbstract=null), Reference(id=1330184376098336863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Expedited Programs for Serious Conditions – Drugs and Biologics [EB/OL]. [2014-03].
https://www.fda.gov/media/119293/download., articleTitle=null, refAbstract=null), Reference(id=1330184376161251424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=DYE E S, GROSKOPH J, KELLEY B,
et al. CMC considerations when a drug development project is assigned breakthrough therapy status [J].
Pharm Eng, 2015,
35(1):1-11., articleTitle=null, refAbstract=null), Reference(id=1330184376228360289, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=国务院.关于改革药品医疗器械审评审批制度的意见[EB/OL].[2015-08-18].
http://www.gov.cn/zhengce/content/2015-08/18/content_10101.htm., articleTitle=null, refAbstract=null), Reference(id=1330184376278691938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=国务院办公厅.关于深化审评审批制度改革鼓励药品医疗器械创新的意见[EB/OL].[2017-10-08].
http://www.gov.cn/xinwen/2017-10/08/content_5230105.htm., articleTitle=null, refAbstract=null), Reference(id=1330184376341606499, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.中华人民共和国药品管理法[EB/OL].[2019-08-27].
http://www.gov.cn/xinwen/2019-08/26/content_5424780.htm., articleTitle=null, refAbstract=null), Reference(id=1330184376396132452, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=国家市场监督管理总局.药品注册管理办法[EB/OL].[2020-01-22].
http://www.gov.cn/gongbao/content/2020/content_5512563.htm., articleTitle=null, refAbstract=null), Reference(id=1330184376459047013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Content and Format of Investigational New Drug Applications(INDs) for Phase 1 [EB/OL]. [1995-11].
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/content-and-format-investigational-new-drug-applications-inds-phase-1-studies-drugs-including-well., articleTitle=null, refAbstract=null), Reference(id=1330184376526155878, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products [EB/OL]. [2007-03-05].
https://www.ema.europa.eu/en/strategies-identify-mitigate-risks-first-human-early-clinical-trials-investigational-medicinal., articleTitle=null, refAbstract=null), Reference(id=1330184376610041959, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Requirements for quality documentation concerning biological investigational medicinal products in clinical trials[EB/OL]. [2012-05-14].
https://www.ema.europa.eu/en/requirements-quality-documentation-concerning-biological-investigational-medicinal-products-clinical., articleTitle=null, refAbstract=null), Reference(id=1330184376681345128, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.关于发布新药Ⅰ期临床试验申请技术指南的通告[EB/OL].[2018-01-25].
https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/ggtg/qtggtg/20180125135801903.html., articleTitle=null, refAbstract=null), Reference(id=1330184376765231209, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.关于发布生物制品注册分类及申报资料要求的通告[EB/OL].[2020-07-01].
https://www.nmpa.gov.cn/yaopin/ypggtg/ypqtgg/20200630175301552.html., articleTitle=null, refAbstract=null), Reference(id=1330184376849117290, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.关于《临床试验期间生物制品药学研究和变更技术指导原则》(上网征求意见稿)征求意见的通知.[EB/OL].[2020-09-10].
https://www.cde.org.cn/main/news/viewInfoCommon/3e7f133e8a854894fafa49752d7d8a9e., articleTitle=null, refAbstract=null), Reference(id=1330184376933003371, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. CGMP for Phase 1 Investigational Drugs [EB/OL]. [2008-07].
https://www.fda.gov/media/70975/download, articleTitle=null, refAbstract=null), Reference(id=1330184377054638188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=EUROPEAN COMMISSION. Good Manufacturing Practice(GMP) guidelines-Annex 13 [EB/OL]. [2017-08-12].
https://ec.europa.eu/health/medicinal-products/eudralex/eudralex-volume-4_en., articleTitle=null, refAbstract=null), Reference(id=1330184377167884397, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.关于发布《药品生产质量管理规范(2010年修订)》临床试验用药品附录的公告[EB/OL].[2022-05-27].
https://www.nmpa.gov.cn/xxgk/fgwj/xzhgfxwj/20220527182006196.html, articleTitle=null, refAbstract=null), Reference(id=1330184378786885743, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Chemistry, Manufacturing, and Control(CMC) Information for Human Gene Therapy Investigational New Drug Applications(INDs) [EB/OL]. [2020-01].
https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/UCM610795.pdf., articleTitle=null, refAbstract=null), Reference(id=1330184378904326256, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Friend of Cancer Research. Designing the Future of Cellular Therapies [EB/OL]. [2019-03-31].
https://friendsofcancerresearch.org/wp-content/uploads/Friends_Cellular_Therapies_White_Paper_1.pdf, articleTitle=null, refAbstract=null), Reference(id=1330184378988212337, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=STEWART M D, KEANE A, BUTTERFIELD L H,
et al. Accelerating the development of innovative cellular therapy products for the treatment of cancer [J].
Cytotherapy, 2020,
22(5): 239-246., articleTitle=null, refAbstract=null), Reference(id=1330184379067904114, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Regenerative Medicine Advanced Therapy Designation [EB/OL]. [2017].
https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/regenerative-medicine-advanced-therapy-designation., articleTitle=null, refAbstract=null), Reference(id=1330184379143401587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=MARCHETTI S, SCHELLENS J H M. The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials [J].
Br J Cancer, 2007,
97(5): 577-581., articleTitle=null, refAbstract=null), Reference(id=1330184379210510452, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Exploratory IND Studies [EB/OL]. [2006-01].
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/exploratory-ind-studies, articleTitle=null, refAbstract=null), Reference(id=1330184379290202231, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=TEJWANI V, CHAUDHARI M, RAI T,
et al. High-throughput and automation advances for accelerating single-cell cloning, monoclonality and early phase clone screening steps in mammalian cell line development for biologics production [J].
Biotechnol Prog, 2021,
37(6): e3208., articleTitle=null, refAbstract=null), Reference(id=1330184379357311096, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=KELLEY B. Developing therapeutic monoclonal antibodies at pandemic pace [J].
Nature biotechnol, 2020,
38(5): 540-545., articleTitle=null, refAbstract=null), Reference(id=1330184379424419961, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Z, CHEN J, WANG J H,
et al. Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak [J].
Biotechnol Prog, 2021,
37(5):e3186., articleTitle=null, refAbstract=null), Reference(id=1330184379483140218, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MCGOVERN Ā T, SALISBURY C M, NYBERG G B. The pandemic and resilience for the future: AccBio 2021 [J].
Biotechnol Prog, 2022,
38(1): e3207., articleTitle=null, refAbstract=null), Reference(id=1330184379541860475, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=崔靖,宋丽娜.创新单抗药物申报临床试验病毒安全性相关监管指南调研与技术考量[J].药学学报,2021,
56(4):2308-2314., articleTitle=null, refAbstract=null), Reference(id=1330184379596386428, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=李敏,郭秀侠,刘伯宁.关于生物制品工艺验证的审评实践与思考[J].中国生物制品学杂志,2017,
30(6):664-668., articleTitle=null, refAbstract=null), Reference(id=1330184379667689597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=EVERS A, CLÉNET D, PFEIFFER-MAREK S. Long-term stability prediction for developability assessment of biopharmaceutics using advanced kinetic modeling [J].
Pharmaceutics, 2022,
14(2): 375., articleTitle=null, refAbstract=null), Reference(id=1330184379743187071, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=CAMPA C, PRONCE T, PALUDI M,
et al. Use of stability modeling to support accelerated vaccine development and supply [J].
Vaccines(Basel), 2021,
9(10): 1114., articleTitle=null, refAbstract=null), Reference(id=1330184379818684544, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Innovative Science and Technology Approaches for New Drugs(ISTAND) Pilot Program [EB/OL]. [2023-03-03].
https://www.fda.gov/drugs/drug-development-tool-ddt-qualification-programs/innovative-science-and-technology-approaches-new-drugs-istand-pilot-program., articleTitle=null, refAbstract=null), Reference(id=1330184379881599105, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=DYE E, STURGESS A, MAHESHWARI G,
et al. Examining manufacturing readiness for breakthrough drug development [J].
AAPS PharmSciTech, 2016,
17(3):529-538., articleTitle=null, refAbstract=null), Reference(id=1330184379936125058, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=EFPIA-EBE. White Paper on Expedited CMC Development:Accelerated Access for Medicines of Unmet Medical Need –CMC Challenges and Opportunities [EB/OL]. [2017-12].
https://www.efpia.eu/media/288657/efpia-ebe-white-paper-expedited-cmc-development-accelerated-access-for-medicines-of-unmet-medical-need-december-2017.pdf, articleTitle=null, refAbstract=null), Reference(id=1330184380011622531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies [EB/OL]. [2018-11-26].
https://www.ema.europa.eu/en/events/stakeholder-workshop-support-quality-development-early-access-approaches-such-prime-breakthrough, articleTitle=null, refAbstract=null), Reference(id=1330184380078731396, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH Q12. Technical and regulatory considerations for pharmaceutical product lifecycle management [EB/OL]. [2019-12-20].
https://database.ich.org/sites/default/files/Q12_Guideline_Step4_2019_1119.pdf., articleTitle=null, refAbstract=null), Reference(id=1330184380154228869, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Chemistry, Manufacturing, and Controls Development and Readiness Pilot(CDRP) Program [EB/OL]. [2023-04-01].
https://www.fda.gov/drugs/pharmaceutical-quality-resources/chemistry-manufacturing-and-controls-development-and-readiness-pilot-cdrp-program., articleTitle=null, refAbstract=null), Reference(id=1330184380233920648, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. PQ/CMC and IDMP [EB/OL]. [2023-04-25].
https://www.fda.gov/industry/pharmaceutical-quality-chemistry-manufacturing-controls-pqcmc/pqcmc-and-idmp., articleTitle=null, refAbstract=null), Reference(id=1330184380322001033, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=识林.FDA 药品中心主任谈在云端建立全球质量档案[EB/OL].[2020-01-18].
https://mp.weixin.qq.com/s?__biz=MzA5MDAyNjQxMw==&mid=2650393602&idx=1&sn=58e085f9729a2521e68c5dcb36c353e1&chksm=881c94c0bf6b1dd61d671b149eedfb852087deca24ddb395781dd2a76f8aea0d11a30781984d&scene=21#wechat_redirect [EB/OL]., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330184374454169658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, xref=1., ext=[AuthorCompanyExt(id=1330184374462558267, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374454169658, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Medicine, Tsinghua University, Beijing 100084), AuthorCompanyExt(id=1330184374470946876, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374454169658, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.清华医学院,北京 100084)]), AuthorCompany(id=1330184374533861437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, xref=2., ext=[AuthorCompanyExt(id=1330184374542250046, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374533861437, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.GlaxoSmithKline Company, Beijing 100025), AuthorCompanyExt(id=1330184374550638655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184372222799926, companyId=1330184374533861437, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.葛兰素史克公司,北京 100025)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.06.018, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.06.018, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.06.018, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.06.018, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1686326400000, fullTextJson=null, articleText=null, reference=null)